Team led by Berkeley Lab and UC Berkeley researchers exploits tiny defects in diamonds to pave the way for enhanced biological imaging and drug studies.
The ACS January 2018 Special Biochemistry Issue has included College of Chemistry professors Ming Hammond, Evan Miller, and David Savage among the 44 early career scientists identified as representing the future of biochemistry. These scientists are noted by the publication for tackling problems of biological relevance.
Chemistry Professor Robert Bergman has been named the 2014 recipient of the Welch Award in Chemical Research for “pioneering work in alkane activation and mechanisms of organometallic reactions.”
Jennifer Doudna and Emmanuelle Charpentier were awarded the Japan Prize today for their invention of the revolutionary gene-editing technology known as CRISPR-Cas9, which has swept into research labs around the world and is already yielding new therapies for cancer and hereditary diseases.
To help cancer drugs access tumors, Ting Xu and collaborators are making tiny particles called nanocarriers that protect the drugs during their journey to the tumor. Read the article.
The University of California, Berkeley has joined forces with pharmaceutical giant Novartis to establish a new research collaboration aimed at unlocking difficult drug targets to accelerate the discovery of new medicines in areas such as infectious diseases and cancer.
Team led by Berkeley Lab and UC Berkeley researchers 
The collaborators hope 
The ACS January 2018 Special Biochemistry Issue has included College of Chemistry professors Ming Hammond, Evan Miller, and David Savage among the 44 early career scientists identified as representing the future of biochemistry. These scientists are noted by the publication for tackling problems of biological relevance.
The Green Science Policy Institute recently launched 
Jennifer Doudna and Emmanuelle Charpentier were awarded the Japan Prize today for their invention of the revolutionary gene-editing technology known as CRISPR-Cas9, which has swept into research labs around the world and is already yielding new therapies for cancer and hereditary diseases.
To help cancer drugs access tumors, Ting Xu and collaborators are making tiny particles called nanocarriers that protect the drugs during their journey to the tumor. 
David Savage, assistant professor of chemistry, has won an NIH Director's New Innovator Award.
Ken Raymond, who, thanks to a new DOE grant and a successful startup, is finding his retirement busier than expected.
The University of California, Berkeley has joined forces with pharmaceutical giant Novartis to establish a new research collaboration aimed at unlocking difficult drug targets to accelerate the discovery of new medicines in areas such as infectious diseases and cancer.